Our statement' 'almost all survival statistics after irradiation are still based on follow-up periods of a few months to no more than three to four years' was correct at the time it was submitted (see paragraphs 7-9 of reply to Dr Oosterhuis et al.7).
Our statement that 'patients have the right to be treated by enucleation which eliminates any further dissemination' is progressively becoming more supportable. Death from metastases, disseminated after irradiation, cannot manifest itself before six years after therapy. 'Short-term analyses' of treated patients are irrelevant. Survival rates after enucleation, irradiation, and observation are identical during the first six post-treatment years if the selection conditions have been identical. Results more than six years after irradiation have been published only twice; both were highly unfavourable.'l After enucleation any (further) dissemination is prevented. After irradiation major parts of the remaining tumour tissue (69% after a two-year follow-up period") continue their growth and will shed cell emboli, eventually causing metastatic death after more than six years. 
